| Tag | Content |
|---|
EnhancerAtlas ID | HS164-05130 |
Organism | Homo sapiens |
Tissue/cell | Raji |
Coordinate | chr17:7034960-7036510 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| HES2 | MA0616.2 | chr17:7035637-7035647 | GGCACGTGCC | + | 6.02 | | HES2 | MA0616.2 | chr17:7035637-7035647 | GGCACGTGCC | - | 6.02 | | IRF1 | MA0050.2 | chr17:7035779-7035800 | AAAAAAAAAAAGAAAGAAAGA | - | 6.25 | | IRF1 | MA0050.2 | chr17:7035813-7035834 | AAAGAAAAAGAGGAACTAAAA | - | 6.32 | | NR2C2 | MA0504.1 | chr17:7036015-7036030 | TGACCCCTGACCCCT | - | 7.2 | | Nr2f6(var.2) | MA0728.1 | chr17:7035063-7035078 | GAGGTCAGGAGTTCA | + | 6.22 | | SPI1 | MA0080.4 | chr17:7035817-7035831 | AAAAAGAGGAACTA | + | 6.66 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_09336 | chr17:7032154-7043631 | CD14 | | SE_68171 | chr17:7013178-7041452 | TC32 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr17 | 7035816 | 7036492 | | chr17 | 7035868 | 7036444 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH17I007130 | chr17 | 7033542 | 7037519 |
|
Enhancer Sequence | ACAACAGTGA GAAGATGTCA GATTAAAAGC AGATCATGTC AGGGTGCGGT GGCTCACGCC 60
TGTAACCCCA GCACTTTGGG AGGCTGAGGT GGGTGGATCC TCTGAGGTCA GGAGTTCAAG 120
ACCAGCCTGG CCAACATGGA GAAACCCCAT CTCTACTAAA AATACAAAAA AAAAAAAAAA 180
TTAGCTGGGC ATGGTGGCAG GCGCCTGTAA TCACAGCTAC ACAGGAGGCT GAGGCAGGAG 240
AATCGCTTGA ACCCGGGAGG CGGAGGTTGC AGTGAGCCAA GATTGTACCA CTGCACTCCA 300
GCCTGGGCGC CAAGAGCGAA GTCTCCGTCT CAAAAAACAA AAGGGTAGAT AGTGAATCTT 360
GGAGGAAGAA CCATCAACTC AGCACTGGCT GGGGAGGGCC TGTGGGCGAG GAAAGGAAGG 420
CTTCCTGAAG AAGCTTTGTA TGCTGCTGAG AAAGTGACAG CAGGGTTAAC TGAGCGGGAA 480
GAGGGGGCAG GAATGGGTTA AACGCGCAAT GTAGAAAGAG GAACTGAAAG GGCCGGGCGC 540
GGTGGGTCAT GCCTGTAATC CCGGCACTTT GGGAGGCCCA GGGAGGCAGA TCACTTGAGG 600
TCAGGAGTTC GAGACCAGCC TGGCCAACAT GGTGAAACTC CATCTCTACT AAAAATATAA 660
AATTAGCCGG GCGTGGTGGC ACGTGCCCGT AATCCCAGTT ACTCGGGAGG CTGAGGCAGG 720
AGAATCCCTT GAACCCAGGA GGCGGAGGTT GCAGTGAGCT GAGATCACGT TATTGCACTC 780
TAGCCTGGGC AACAAGAGCA AAACTCCATC TCAAAAAAAA AAAAAAAAAA GAAAGAAAGA 840
AAGAAAGAAA AGAAAAGAAA AAGAGGAACT AAAAAGAGCT CAATTTGGGA TAGACGGTGT 900
TTGTGTTTGA GGTCCCTGTT AGACCCTAAG GTGAGATGCC AGGGCAGAAG CTGAATAAAC 960
AATCCAGGCA GGAACACACA CTCACACACA TTGACCCCAA TCCCATGAGC CCCATTGTCC 1020
TGAAGACACA TCCCTGCTCC TGCCCAGCTG GTCCCTGACC CCTGACCCCT GGCTATGCTG 1080
GCCTCAGATC TGTGTCTCCT TCTCAAGTCA TTGGCCCCCA GGGCCACTGT CCCTCCGTCT 1140
CCACTGGGTG CACTGGAAAG GCAGGGTGAG GTACAAGAAG CCCCATTTAA AACCATGAAA 1200
TCAGCAGCTC AAACACCAGA AAGTCCCCAG CTTTTGCAAC AGCTCATAAG GACTGGTGTT 1260
TCCTGCGAGC AGTGACACCC TGCAGGTTTC TAAACTCTGC TTCTCTTTGT TTTGTAAAGC 1320
AGTGTTCTAT CAGTCCCGGA AAGCCCCTGG AGTGGATCAC GCCTCCCTAA TCTACCGTGT 1380
TCTGCATTTA TCTGCATCTG CAATGTTTGT TGTGGTCTTG TTGCTAGAGG CCTCGTTCCC 1440
CCTGCCTGGT TTATAAAATC CATGTAACCC AGGATTTTTT GTGGTGTGGA TACTCTACAT 1500
TGAAAGGACA TGCATGCTTT CTATTTTATT TATTTATTTA TTTATTATTT 1550
|
